Rocklea Showgrounds Now One of the First QLD Vaccination Hubs

Did you know that 14 community hubs in Brisbane, including one in Rocklea Showgrounds, are now open for youth vaccinations?



One of the first of the 14 vaccination hubs to open in Brisbane is the Rocklea Showgrounds hub, with people lining up to receive the Pfizer vaccine after the community registered their interest in May 2021. The establishment of these hubs marks Queensland’s push towards mass vaccination, which is estimated to begin later in the year once supply increases.

Health Minister Yvette D’Ath commented that all 14 hubs are expected to be open before July, ready to offer vaccines to people under the age of 40. Because health workers initially anticipated to get five shots out of each Pfizer vaccine and discovered that they could actually get six, surplus vaccines will be used at the hubs. This means that five appointments can be made per vial, even if there were six shots. 

According to Ms D’Ath, all of the community hubs will provide Pfizer vaccines. Though Queensland is readying itself for mass vaccination, not everyone is eligible to receive their shots just yet. Those eligible for vaccination must fall under either the following priority groups:

1a priority group

  • COVID-19 frontliners and  healthcare workers.
  • Quarantine and border workers.
  • Staff and residents at aged care communities. 
  • Disability care residents and staff. 

1b priority group

  • Anyone aged 70 or older. 
  • Aboriginal and Torres Strait Islander adults aged 50 or older.
  • Young adults with underlying medical conditions.
  • People living with disabilities. 

The new vaccination hub can be found at the Rocklea Showgrounds at Goburra St and Ipswich Rd, Rocklea. 

Luina Bio Confident They Can Help Make New Generation mRNA Vaccines Against COVID-19

Darra-based biotech startup company Luina Bio believes they have the ingredients and the expertise necessary to help produce a new generation of mRNA vaccines to help in the fight against COVID-19. 



mRNA vaccines, like the one produced by pharmaceutical giant Pfizer, are at the forefront of the worldwide efforts to contain the coronavirus pandemic.

At the present moment, Luina Bio helps prepare vaccines and proteins for researchers and companies worldwide, with more than 90 per cent of its business coming from overseas clients. 

“As a microbial fermentation company, Luina Bio has all the capacity to produce the API – the active pharmaceutical – for mRNA vaccines,” Max Rosetto, Luina’s General Manager (Business Development) explained at a BioMelbourne Network event recently. 

Their current capacity allows them to produce 1.4 million doses of the active drug for the vaccines — a number which can be increased to 20 million doses with some investment. 

The federal government began discussing the production of the vaccines with numerous local manufacturers, Luina Bio included, in 2020. Government plans are already in place for a COVID-19 vaccine roll-out, with smaller startups volunteering to partake in the creation of mRNA vaccines in the future.

However, Karen Andrews, Minister for Industry, Science and Technology, reiterated that the production of mRNA products at scale is challenging and will take time to develop. 

About Luina Bio

Luina Bio, founded and based in Brisbane, has served pharmaceutical, biotechnology, and veterinary industries across the globe for over 20 years by supplying them with manufacturing solutions for biological drugs. 

Their primary clients consist of research institutes, universities, and biopharmaceutical development companies. Luina Bio’s manufacturing includes, but is not limited to, recombinant proteins and vaccines, live biotherapeutics, plasmid DNA, and human and veterinary products.
For more information, visit their website.